FDA Approved: SABRIL — Supplemental Application (Lundbeck Pharmaceuticals LLC)

View source ↗

Summary

The FDA approved a supplemental application for Sabril (vigabatrin) by Lundbeck Pharmaceuticals LLC, resulting in a label change to reflect updated epilepsy ind…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complex Partial Seizures
• Epilepsy
• Infantile Spasms

Drugs mentioned

• SABRIL (VIGABATRIN)

Snippet

SUPPL AP for SABRIL (VIGABATRIN)